GC Genome Corporation (KOSDAQ:340450)
South Korea
· Delayed Price · Currency is KRW 7,700.00
+70.00 (0.92%)
At close: Dec 5, 2025
GC Genome Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | 2,441 | -1,257 | -550.1 | -3,763 | 293.2 | -2.67 | Upgrade
|
| Depreciation & Amortization | 2,961 | 3,219 | 3,541 | 2,807 | 2,057 | 980.99 | Upgrade
|
| Loss (Gain) From Sale of Assets | -3.66 | -1.36 | -1.57 | 44.89 | 13.83 | 0.29 | Upgrade
|
| Asset Writedown & Restructuring Costs | 436.18 | 1,125 | - | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | 2.93 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 23.23 | 7.42 | -4.25 | -6.17 | 29.55 | 8.24 | Upgrade
|
| Other Operating Activities | -732.13 | -176.66 | 1,702 | 1,897 | -1,225 | 462.61 | Upgrade
|
| Change in Accounts Receivable | -4,380 | -1,133 | -83.41 | -517.76 | -2,128 | -295.63 | Upgrade
|
| Change in Inventory | -528.25 | -97.71 | 30.87 | -617.92 | -610.08 | - | Upgrade
|
| Change in Accounts Payable | 148.46 | -851.58 | -459.75 | 17.83 | 1,293 | - | Upgrade
|
| Change in Other Net Operating Assets | 325.33 | -457.3 | -834.42 | -1,474 | 207.98 | -484.83 | Upgrade
|
| Operating Cash Flow | 691.24 | 377.99 | 3,340 | -1,610 | -67.7 | 668.99 | Upgrade
|
| Operating Cash Flow Growth | -79.31% | -88.69% | - | - | - | -25.29% | Upgrade
|
| Capital Expenditures | -280.29 | -328.59 | -7,406 | -4,029 | -2,868 | -2,416 | Upgrade
|
| Sale of Property, Plant & Equipment | 5.86 | - | - | 813.98 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -119.37 | -87.11 | -49.42 | -40.7 | -169.27 | -234.61 | Upgrade
|
| Investment in Securities | -10,947 | 3,819 | -4,965 | 8,950 | 5,236 | -18,999 | Upgrade
|
| Other Investing Activities | -148.08 | -275.52 | -55.46 | -517.26 | -302.52 | -309.28 | Upgrade
|
| Investing Cash Flow | -11,489 | 3,128 | -12,476 | 5,177 | 1,897 | -21,960 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 2,900 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 20,000 | Upgrade
|
| Total Debt Issued | - | - | - | - | - | 22,900 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -3,000 | Upgrade
|
| Long-Term Debt Repaid | - | -615.54 | -859.19 | -671.84 | -490.16 | -2,264 | Upgrade
|
| Total Debt Repaid | -649.89 | -615.54 | -859.19 | -671.84 | -490.16 | -5,264 | Upgrade
|
| Net Debt Issued (Repaid) | -649.89 | -615.54 | -859.19 | -671.84 | -490.16 | 17,636 | Upgrade
|
| Issuance of Common Stock | 40,437 | - | - | - | - | 10,000 | Upgrade
|
| Financing Cash Flow | 39,787 | -615.54 | -859.19 | -671.84 | -490.16 | 27,636 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.03 | 0.01 | -5.41 | -0.99 | - | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | - | - | - | -0 | - | Upgrade
|
| Net Cash Flow | 28,989 | 2,891 | -10,000 | 2,894 | 1,339 | 6,346 | Upgrade
|
| Free Cash Flow | 410.95 | 49.4 | -4,065 | -5,639 | -2,935 | -1,747 | Upgrade
|
| Free Cash Flow Margin | 1.33% | 0.19% | -14.90% | -23.39% | -15.87% | -12.89% | Upgrade
|
| Free Cash Flow Per Share | 19.93 | 2.71 | -221.71 | -349.17 | -183.51 | -98.03 | Upgrade
|
| Cash Interest Paid | 192.54 | 210.9 | 173.16 | 116.04 | - | 83.54 | Upgrade
|
| Cash Income Tax Paid | 46.58 | -2.53 | -3.1 | -54.92 | 31.28 | 15.18 | Upgrade
|
| Levered Free Cash Flow | - | -3,001 | -7,596 | -933.3 | -3,846 | -2,369 | Upgrade
|
| Unlevered Free Cash Flow | - | -2,401 | -7,021 | 126.36 | -2,919 | -2,294 | Upgrade
|
| Change in Working Capital | -4,434 | -2,539 | -1,347 | -2,592 | -1,236 | -780.47 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.